LEADER SPOTLIGHT
Jed Litwiniuk, MHA
Chief Executive Officer
“We are focused on transforming cardiovascular care through innovation and science. Our teams, tools, and technologies support our R&D strategy, with a focus on value-added medicines and a simplified regulatory pathway to ensure efficient access for patients."

Our mission
We are dedicated to addressing unmet medical needs in cardiovascular health by transforming and enhancing existing medications. Our mission is to improve patient outcomes by delivering Value-Added Medications in convenient dosage forms that benefit patients, healthcare providers, and payors alike.
We focus on adding value to medicines with well established clinical history by optimizing their
Aligning science and experience to change the world

Jed Litwiniuk, MHA
Chief Executive Officer
Uwe Tigör, MD
Chief Medical Officer
Dawid Chabowski, PhD
Science & Operational Manager
Pascal St-Laurent
Pharmaceutical Development Consultant
Anthony Grenier
Tech Transfer & CMC Consultant
Len S. Smith
Chief IP CounselScientific Advisory Board

Juan Kaski, Professor of Medicine
Medical Advisor
Michael Weber, Professor of Medicine
Cardiology Advisor
Giora Davidai, MD
Medical Advisor